Perceptions of chronic myelogenous leukemia (CML) and how to live with it are very different for patients and physicians, and a strong dialogue is needed to overcome the disparity, according to Jan Geissler, co-founder of the CML Advocates Network.

At the 56th Annual Meeting of the American Society of Hematology in San Francisco, California, December 6-9, he discussed how there has been a lot of movement and a number of studies in the past years to help understand how CML patients perceive quality of life and severity of side effects.

“Especially in CML we’ve seen a lot of movement, because a very lethal disease, in the last 15 years, has turned into a chronic disease,” Mr Geissler said.

свернуть